Overall market sentiment has been down on Chembio Diagnostics Inc (CEMI) stock lately. CEMI receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With CEMI Stock Today?
Chembio Diagnostics Inc (CEMI) stock is trading at $5.38 as of 1:22 PM on Thursday, Dec 17, a rise of $0.32, or 6.28% from the previous closing price of $5.06. The stock has traded between $5.07 and $5.50 so far today. Volume today is low. So far 839,630 shares have traded compared to average volume of 2,097,981 shares.
To screen for more stocks like Chembio Diagnostics Inc click here.
More About Chembio Diagnostics Inc
Chembio Diagnostics Inc is a US-based company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
Click Here to get the full Stock Score Report on Chembio Diagnostics Inc (CEMI) Stock.
